Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramesh K Ramanathan

Showing results (1-10 of 179) with videos related to

Pageof 18
Sort By:
Clinical Advances in Hematology & Oncology : H&O|February 13, 2014
Current and emerging treatment options in pancreatic cancerRamesh K Ramanathan
Clinical Colorectal Cancer|November 28, 2008
Alternative dosing schedules for cetuximab: a role for biweekly administration?Ramesh K Ramanathan
Journal of Clinical Gastroenterology|December 18, 2001
Treatment of colon and rectal cancerDavid Blumberg, Ramesh K Ramanathan
Chinese Clinical Oncology|January 9, 2018
Targeting the stroma in pancreatic cancerDaniel H Ahn, Ramesh K Ramanathan
Clinical Lymphoma & Myeloma|June 27, 2006
17-dimethylaminoethylamino-17-demethoxygeldanamycin in patients with advanced-stage solid tumors and lymphoma: a phase I studyFiras N Shadad, Ramesh K Ramanathan
Clinical Colorectal Cancer|October 10, 2006
Ocular toxicity related to cetuximab monotherapy in patients with colorectal cancerShelley Dranko, Connie Kinney, Ramesh K Ramanathan
Gastroenterology|November 26, 2009
What's causing this woman's chest pain?Tara Iyengar, Ramesh K Ramanathan, Philip J Gold
Journal of the American College of Surgeons|September 4, 2007
Update for surgeons: recent and noteworthy changes in therapeutic regimens for cancer of the colon and rectumClaudia Hriesik, Ramesh K Ramanathan, Steven J Hughes
Cancers|June 13, 2018
Emerging Therapies and Future Directions in Targeting the Tumor Stroma and Immune System in the Treatment of Pancreatic AdenocarcinomaDaniel H Ahn, Ramesh K Ramanathan, Tanios Bekaii-Saab
Clinical Breast Cancer|July 7, 2011
Development of breast cancer in a 21-year-old childhood Wilms' tumor survivor with a BRCA1 2634delC mutationAlexandra M Dulude, Joyce D'Souza, Nedra Harrison, et al.
Pageof 18

Showing results (1-10 of 179) with videos related to

Sort By:
Pageof 18
Clinical Advances in Hematology & Oncology : H&O|February 13, 2014
Current and emerging treatment options in pancreatic cancerRamesh K Ramanathan
Clinical Colorectal Cancer|November 28, 2008
Alternative dosing schedules for cetuximab: a role for biweekly administration?Ramesh K Ramanathan
Journal of Clinical Gastroenterology|December 18, 2001
Treatment of colon and rectal cancerDavid Blumberg, Ramesh K Ramanathan
Chinese Clinical Oncology|January 9, 2018
Targeting the stroma in pancreatic cancerDaniel H Ahn, Ramesh K Ramanathan
Clinical Lymphoma & Myeloma|June 27, 2006
17-dimethylaminoethylamino-17-demethoxygeldanamycin in patients with advanced-stage solid tumors and lymphoma: a phase I studyFiras N Shadad, Ramesh K Ramanathan
Clinical Colorectal Cancer|October 10, 2006
Ocular toxicity related to cetuximab monotherapy in patients with colorectal cancerShelley Dranko, Connie Kinney, Ramesh K Ramanathan
Gastroenterology|November 26, 2009
What's causing this woman's chest pain?Tara Iyengar, Ramesh K Ramanathan, Philip J Gold
Journal of the American College of Surgeons|September 4, 2007
Update for surgeons: recent and noteworthy changes in therapeutic regimens for cancer of the colon and rectumClaudia Hriesik, Ramesh K Ramanathan, Steven J Hughes
Cancers|June 13, 2018
Emerging Therapies and Future Directions in Targeting the Tumor Stroma and Immune System in the Treatment of Pancreatic AdenocarcinomaDaniel H Ahn, Ramesh K Ramanathan, Tanios Bekaii-Saab
Clinical Breast Cancer|July 7, 2011
Development of breast cancer in a 21-year-old childhood Wilms' tumor survivor with a BRCA1 2634delC mutationAlexandra M Dulude, Joyce D'Souza, Nedra Harrison, et al.
Pageof 18